Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding SBIO?
Track your performance easily
SBIO Price & Analysis
SBIO ETF Chart & Stats
Day’s Range― - ―
52-Week Range$25.05 - $42.73
Previous Close$36.89
VolumeN/A
Average Volume (3M)7.41K
AUM122.03M
NAV36.99
Expense Ratio0.50%
Holdings Count102
Beta1.45
Inception DateDec 31, 2014
Last Dividend Ex-Date
Dec 21, 2023Dividend Yield
0.07 (0.19%)Shares Outstanding3,125,000
Standard Deviation0.08
10 Day Avg. Volume12,179
30 Day Avg. Volume7,406
Alpha-0.00555
ALPS Medical Breakthroughs ETF (SBIO) Fund Flow Chart
ALPS Medical Breakthroughs ETF (SBIO) 1 year Net Flows: -$1M
SBIO ETF News
PremiumCompany Announcements
Denali Therapeutics Advances Brain Disease Therapies
SBIO ETF FAQ
What was SBIO’s price range in the past 12 months?
SBIO lowest ETF price was $25.05 and its highest was $42.73 in the past 12 months.
What is the AUM of SBIO?
As of Nov 15, 2024 The AUM of SBIO is 122.03M.
Is SBIO overvalued?
According to Wall Street analysts SBIO’s price is currently Undervalued.
Does SBIO pay dividends?
SBIO pays a Notavailable dividend of $0.07 which represents an annual dividend yield of 0.19%. See more information on SBIO dividends here
How many shares outstanding does SBIO have?
SBIO has 3,125,000 shares outstanding.
Which hedge fund is a major shareholder of SBIO?
Currently, no hedge funds are holding shares in SBIO
SBIO ETF Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Corcept Therapeutics
3.84%
Krystal Biotech, Inc.
3.53%
Avidity Biosciences Inc
3.38%
Arcellx, Inc.
3.19%
Alkermes plc
3.08%
Crinetics Pharma
2.97%
Immunovant, Inc.
2.53%
Denali Therapeutics
2.29%
Verona Pharma
2.12%
Agios Pharmaceuticals
2.08%
Total29.00%
ETF Description
ALPS Medical Breakthroughs ETF
SBIO tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials.